Elite Pharmaceuticals (ELTP) 10-K2024 FY Annual report

Filed: 1 Jul 24, 4:59pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absence, adequacy, aging, AI, alerting, ambiguity, Amide, amplify, anniversary, API, appointed, artificial, assumption, attainment, automate, automated, AWP, bad, biased, biosimilar, biotech, Bitartrate, Black, bookkeeping, Centennial, CII, composition, confer, contrary, COSO, CSF, cum, cured, curve, cybersecurity, delete, deployed, deploying, discriminatory, Dolophine, double, driven, emanating, exceeded, exceeding, exempt, exhausted, explain, filled, GDP, Harnessing, headcount, horizon, incident, intelligence, invoice, invoiced, IP, IRA, Iselin, Island, KPMG, laude, lessee, macroeconomic, malfunction, Methotrexate, Mirror, misjudgment, Multisource, NASDAQ, NIST, noncompliance, Noncompliant, Norco, NSO, opportunity, orphan, overhead, patentee, pattern, Percocet, perpetual, phishing, predecessor, privacy, privileged, prompt, purportedly, ransomware, recurrence, relinquish, remote, residual, retrospective, sample, SAR, secrecy, secret, segregation, shale, simplified, specialist, spouse, statutorily, stay, stemming, subtracting, suggested, summa, susceptible, team, top, traffic, transformative, transmission, transmit, unbilled, uncommon, underway, unfavorable, unissued, unsupported, vault

Removed: accreted, Appendix, aspect, capacity, close, COD, collaborative, commensurate, compatible, compromise, computing, concentrate, Concurrently, converted, depreciated, destruction, detriment, digital, discourage, dismantlement, efficient, emerged, evolution, exchanged, existent, expiring, fix, GDUFA, hardware, hereinafter, indexed, intensify, intrusion, IQVIA, leased, leasehold, liquid, mentioned, notably, prerequisite, presumption, proportion, proposal, QVIA, redeemed, redemption, remained, rendering, safeguard, Sandy, stabilize, Superstorm, tampering, tenant, tender, threaten, threshold, transferable, undergoing, unintentional, uninterrupted, vulnerability, wait, warehousing, widely

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated ELTP transcripts

ELTP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following documents of our report dated June 29, 2023, relating to the consolidated financial statements of Elite Pharmaceuticals, Inc. and Subsidiary, included in the Annual Report on Form 10-K of the Company for the year ended March 31, 2024.

Registration Statement No. 333-197694 on Form S-8

Registration Statement No. 333-163907 on Form S-8

Registration Statement No. 333-132140 on Form S-8

Registration Statement No. 333-118524 on Form S-8

Registration Statement No. 333-239847 on Form S-3

Registration Statement No. 333-278317 on Form S-8

Registration Statement No. 333-278318 on Form S-8

/s/ Buchbinder Tunick & Company LLP

Little Falls, New Jersey

July 1, 2024